Form 4: Axogen Director Sells Shares
Insider Transaction (Form 4)
Amy Mcbride Wendell, a Director of Axogen, Inc., sold 13,353 shares of common stock on August 11, 2026 for $48.42 per share.
Summary
- Option exercise/conversion: acquired 13,353 Common Stock at $14.85 ($198,292) on August 11, 2026; holds 121,329 after (Direct).
- Open-market sale: disposed of 13,353 Common Stock at $48.42 ($646,592) on August 11, 2026; holds 107,976 after (Direct).
- Option exercise/conversion: disposed of 13,353 Employee Stock Option (right to purchase) on August 11, 2026 (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $646,592 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Amy Mcbride Wendell — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-11 | Option exercise/conversion | Common Stock | 13,353 | $15 | $198.3K | 121,329 |
| 2026-08-11 | Open-market sale | Common Stock | 13,353 | $48 | $646.6K | 107,976 |
| 2026-08-11 | Option exercise/conversion | Employee Stock Option (right to purchase) | 13,353 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-11 | Option exercise/conversion (13,353 shares) |
| 2026-08-11 | Open-market sale (13,353 shares) |
| 2026-08-11 | Option exercise/conversion (13,353 shares) |
Keywords
insider transaction, Form 4, AXGN, Axogen, Inc., bearish, Amy Mcbride Wendell
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.